Economic impact of hypoglycemia among insulin-treated patients with diabetes

References

• American Diabetes Association. Standards of Medical Care in Diabetes - 2015. Diabetes Care 2015;38(1 Suppl):S8-S16
   Google Scholar
• Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab Res Rev 2008;24:87-92
   PubMed Web of Science ®Google Scholar
• Choudhary P, Amiel SA. Hypoglycaemia: current management and controversies. Postgrad Med J 2011;87:298-306
   PubMed Web of Science ®Google Scholar
• Elliott L, Fidler C, Ditchfield A, et al. Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated diabetes. Diabetes Ther 2016;7:45-60
   PubMed Web of Science ®Google Scholar
• Heaton A, Martin S, Brelje T. The economic effect of hypoglycemia in a health plan. Manag Care Interface 2003;16:23-7
   PubMedGoogle Scholar
• Quilliam BJ, Simeone JC, Ozbay AB, et al. The incidence and costs of hypoglycemia in type 2 diabetes. Am J Manag Care 2011;17:673-80
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Thomsen TL, et al. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
   PubMed Web of Science ®Google Scholar
• Golden SH, Brown T, Yeh HC, et al. Methods for insulin delivery and glucose monitoring: comparative effectiveness. AHRQ comparative effectiveness reviews. Rockville, MD: Agency for Healthcare Research and Quality (US), 2012
   Google Scholar
• Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-32
   PubMed Web of Science ®Google Scholar
• The Henry J Kaiser Family Foundation. Workers by Occupational Category, states (2010-2011), U.S. (2011). Census Bureau March 2011 and 2012 Current Population Survey 2011. Menlo Park, CA: The Henry J Kaiser Family Foundation, Urban Institute, 2011. Available at: URL: http://www.statehealthfacts.org/comparemaptable.jsp?ind=748&cat=1. Accessed June 23, 2016
   Google Scholar
• Howden L, Meyer J. United States Census Bureau: Age and Sex Composition 2010. Washington, D.C.: U S Department of Commerce, 2011. Available at: URL: www.census.gov/population/age/data/2010comp.html. Accessed April 27, 2015
   Google Scholar
• Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
   Google Scholar
• Centers for Disease Control and Prevention NCfHS. Summary Health Statistics for U.S. Adults: National Health Interview Survey. Hyattsville, MD: U S Department of Health and Human Services, 2012
   Google Scholar
• Bureau of Labor Statistics. National compensation survey: occupational earnings in the United States 2010. Washington, D.C.: Bureau of Labor Statistics, 2011. Available at: URL: http://www.bls.gov/ncs/. Accessed June 23, 2016
   Google Scholar
• The Henry J Kaiser Family Foundation. Medicare and nonelderly people with disabilities. Menlo Park, CA: The Henry J Kaiser Family Foundation, Urban Institute, 2010. Available at: URL: http://www.kff.org/medicare/upload/8100.pdf. Accessed June 23, 2016
   Google Scholar
• Caplan C. What share of beneficiaries' total health care costs does medicare pay? AARP Public Policy Institute, Washington, D.C.: Data Digest; 2002. Report No.: 2002:78
   Google Scholar
• Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994;125:177-88
   Google Scholar
• Miller ME, Bonds DE, Gerstein HC, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010;340:b5444
   PubMed Web of Science ®Google Scholar
• Heller SR, Choudhary P, Davies C, et al. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7
   PubMed Web of Science ®Google Scholar
• Rhoads GG, Orsini LS, Crown W, et al. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J Occup Environ Med 2005;47:447-52
   PubMed Web of Science ®Google Scholar
• Ly TT, Nicholas JA, Retterath A, et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240-7
   PubMed Web of Science ®Google Scholar
• Huang ES, O'Grady M, Basu A, et al. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 2010;33:1269-74
   PubMed Web of Science ®Google Scholar
• Kamble S, Schulman KA, Reed SD. Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States. Value Health 2012;15:632-8
   PubMed Web of Science ®Google Scholar
• Ly TT, Brnabic AJ, Eggleston A, et al. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes. Value Health 2014;17:561-9
   PubMed Web of Science ®Google Scholar
• Bronstone A, Graham C. the potential cost implications of averting severe hypoglycemic events requiring hospitalization in high-risk adults with Type 1 Diabetes Using real-time continuous glucose monitoring. J Diabetes Sci Technol 2016.
   PubMedGoogle Scholar
• Tarride JE, Hopkins R, Blackhouse G, et al. A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment. Pharmacoeconomics 2010;28:255-77
   PubMed Web of Science ®Google Scholar
• Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-76
   PubMed Web of Science ®Google Scholar
• Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015;38:971-8
   PubMed Web of Science ®Google Scholar
• Powers AC, Wexler JA, Lash RW, et al. Affordable Care Act Implementation: Challenges and Opportunities to Impact Patients With Diabetes. J Clin Endocrinol Metab 2016;101:1315-17
   PubMed Web of Science ®Google Scholar
• McBride M, Eggleston A, Ly T, Jones T. Health-related quality of life in patients with type 1 diabetes and impaired hypoglycaemia awareness: the role of sensor-augmented insulin pump therapy with automated insulin suspension. ISPOR 16th Annual European Congress and 4th Latin America Conference, Dublin, Ireland. 2014. November 2-6, 2013
   Google Scholar
• Bonds DE, Miller ME, Dudl J et al. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data. BMC Endocr Disord 2012;12:5
   PubMed Web of Science ®Google Scholar
• Mayfield JA, White RD. Insulin therapy for type 2 diabetes: rescue, augmentation, and replacement of beta-cell function. Am Fam Physician 2004;70:489-500
   PubMed Web of Science ®Google Scholar